Clinical and pharmacological technologies of personalized medicine: what now and what will happen?
Dmitry Alekseevich Sychev · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · 2019
«Omic» biomarkers are promising tools for personalizing pharmacotherapy, including and mental illness because allow predicting an individual profile of the effectiveness and safety of psychotropic drugs. «Omics» biomarkers include pharmacogenomic, pharmacoproteomic, pharmacotranscriptome, pharmacometabolic biomarkers. A methodology for the development of «omcs» biomarkers of personalization of pharmacotherapy is presented: from assessing the problems of pharmacotherapy to the system of implanting biomarkers into real clinical practice.